Biorasi Received a Majority Investment from Riordan, Lewis & Haden Equity Partners November 16, 2018

November 16, 2018

Overview

Biorasi, LLC announced the completion of a majority investment by Riordan, Lewis & Haden Equity Partners (“RLH”) on November 16, 2018.

Headquartered in Miami, Florida, Biorasi is a full-service CRO with regional offices in Western and Eastern Europe, India, and Japan.

RLH, an investment firm headquartered in Los Angeles, California, is focused on building market-leading companies in healthcare, business services, and government services through organic growth

Significance

Biorasi is a new kind of CRO that brings a disruptive approach to a traditionally conservative industry. By focusing on project management optimization while incorporating a technology-enabled structured methodology, the Company is able successfully execute complex, challenging Phase I – IV trials faster, more efficiently, and with higher quality results than traditional CROs.

Biorasi, already one of the fastest growing CROs, expects that this investment will fuel years of continued growth and innovation.

Crosstree’s Role

Crosstree Capital Partners acted as the exclusive financial advisor to Biorasi.

Biorasi Received a Majority Investment from Riordan, Lewis & Haden Equity Partners November 16, 2018